Early Translational from Disease Team Conversion | University of California, Los Angeles | Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$1,823,545 |
Disease Team Therapy Development – Research | University of California, Los Angeles | Combination Therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$0 |
Disease Team Therapy Planning I | University of California, Los Angeles | Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$68,947 |